Q2 2026 13F · SEC CIK 1812822

Verdad Advisers, LP

Asset managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $104.4M
Reported positions: 210
Top holdings a year, 3 yrs: +22.3%
Average holding period: 2 qtrs

Verdad Advisers, LP is an asset manager that reported 210 positions worth $104.4M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Apple Inc (AAPL, 2.1%), Belite Bio Inc (BLTE, 2.0%), Acadia Pharmaceuticals Inc (ACAD, 2.0%). A portfolio copying its top holdings returned 22.3% a year over the last 3 years, against 22.3% for the S&P 500.

Verdad Advisers, LP holdings largest 50 of 210 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Verdad Advisers, LP 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
AAPLApple Inc	2.1%	—	7,445	—	$2.2M
BLTEBelite Bio Inc	2.0%	2.5%	13,758	-0.4%	$2.1M
ACADAcadia Pharmaceuticals Inc	2.0%	1.7%	82,629	+21.0%	$2.1M
CMCSAComcast Corp New	2.0%	1.3%	84,569	+103.5%	$2.1M
CLDTChatham Lodging Tr	1.8%	1.2%	140,000	+0.0%	$1.9M
TENXTenax Therapeutics Inc	1.7%	1.7%	123,174	+29.2%	$1.8M
SLDESlide Ins Hldgs Inc	1.7%	—	91,070	—	$1.8M
ZYMEZymeworks Inc	1.7%	2.3%	66,688	-19.4%	$1.7M
AMNAmn Healthcare Services Inc	1.6%	1.0%	51,906	+3.8%	$1.7M
XFORX4 Pharmaceuticals Inc	1.6%	—	352,093	—	$1.6M
VSNTVVersant Media Group Inc	1.5%	0.8%	43,503	+129.0%	$1.6M
NTCTNetScout Systems, Inc.	1.4%	—	33,128	—	$1.4M
AADIWhitehawk Therapeutics Inc	1.3%	—	301,483	—	$1.4M
JNJJohnson & Johnson	1.3%	1.5%	5,384	-0.6%	$1.4M
CTNMContineum Therapeutics Inc	1.3%	1.3%	81,014	-5.8%	$1.3M
008064206Jade Biosciences Inc	1.2%	—	56,384	—	$1.3M
CSCOCisco Sys Inc	1.2%	—	10,307	—	$1.2M
NRIXNurix Therapeutics Inc	1.1%	1.5%	49,511	-40.7%	$1.2M
TARAProtara Therapeutics Inc	1.1%	—	312,249	—	$1.2M
BLMNBloomin Brands Inc	1.1%	—	130,000	—	$1.2M
TYRATyra Biosciences Inc	1.1%	—	36,003	—	$1.1M
PARRPar Pac Holdings Inc	1.1%	1.6%	20,000	-11.1%	$1.1M
EWTXEdgewise Therapeutics Inc	1.1%	—	27,234	—	$1.1M
GOOGLAlphabet Inc	1.0%	—	2,900	—	$1.0M
CRICarters Inc	1.0%	1.0%	25,000	+0.0%	$1.0M
VERAVera Therapeutics Inc Class A	1.0%	—	23,487	—	$1.0M
NUVLNuvalent Inc	1.0%	—	8,104	—	$1.0M
DNTHDianthus Therapeutics Inc	0.9%	0.8%	10,062	+15.7%	$981K
ACRSAclaris Therapeutics Inc	0.9%	0.8%	175,272	-11.0%	$927K
OPYOppenheimer Holdings-Cl A	0.9%	—	8,673	—	$915K
VZVerizon Communications Inc	0.8%	—	20,938	—	$887K
MYEMyers Inds Inc	0.8%	—	24,500	—	$865K
ELVNEnliven Therapeutics Inc	0.8%	—	16,957	—	$861K
UVEUniversal Ins Hldgs Inc	0.8%	—	20,558	—	$850K
BNYBank of Ny Mellon Corp	0.8%	1.2%	5,748	-35.8%	$831K
CNXNPc Connection Inc	0.8%	—	11,084	—	$809K
AIIAmerican Integrity Insurance	0.8%	0.9%	42,178	+2.6%	$794K
AMATApplied Matls Inc	0.8%	1.1%	1,089	-62.4%	$787K
AHCOAdapthealth Corp Common Stock	0.7%	1.3%	75,000	-21.1%	$782K
ALLAllstate Corp	0.7%	—	3,279	—	$780K
CLDXCelldex Therapeutics Inc New	0.7%	—	20,704	—	$770K
RVMDRevolution Medicines Inc	0.7%	2.4%	4,053	-81.2%	$759K
HRTGHeritage Insurance Hldgs Inc	0.7%	0.8%	28,575	+7.9%	$745K
SNXTD SYNNEX Corp	0.7%	—	2,780	—	$743K
MOVMovado Group PLC	0.7%	—	18,762	—	$738K
SNDSmart Sand Inc	0.7%	0.7%	142,684	+16.3%	$715K
VRDNViridian Therapeutics Inc	0.7%	0.7%	38,722	+24.2%	$711K
DSGNDesign Therapeutics, Inc.	0.7%	1.1%	47,557	-48.5%	$688K
MMIMarcus & Millichap Inc	0.7%	—	21,972	—	$685K
SWMMativ Holdings Inc	0.7%	—	90,000	—	$681K

What Verdad Advisers, LP bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

VSNTV Versant Media Group Inc+129.0% shares
CMCSA Comcast Corp New+103.5% shares
TENX Tenax Therapeutics Inc+29.2% shares
VRDN Viridian Therapeutics Inc+24.2% shares
ACAD Acadia Pharmaceuticals Inc+21.0% shares
SND Smart Sand Inc+16.3% shares
DNTH Dianthus Therapeutics Inc+15.7% shares
HRTG Heritage Insurance Hldgs Inc+7.9% shares

Reduced

RVMD Revolution Medicines Inc-81.2% shares
AMAT Applied Matls Inc-62.4% shares
DSGN Design Therapeutics, Inc.-48.5% shares
NRIX Nurix Therapeutics Inc-40.7% shares
BNY Bank of Ny Mellon Corp-35.8% shares
AHCO Adapthealth Corp Common Stock-21.1% shares
ZYME Zymeworks Inc-19.4% shares
PARR Par Pac Holdings Inc-11.1% shares

Left the top 50

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +31.4% /yr; S&P 500 +11.7%
3 years: +22.3% /yr; S&P 500 +22.3%
5 years: +9.9% /yr; S&P 500 +10.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$104.4M	210
Q1 2026	$88.8M	179
Q4 2025	$87.4M	104
Q3 2024	$74.9M	92
Q2 2024	$86.6M	110
Q1 2024	$91.9M	147
Q4 2023	$49.3M	53
Q3 2023	$65.4M	51
Q2 2023	$63.8M	46
Q1 2023	$49.7M	38
Q4 2022	$99.2M	29
Q3 2022	$68.8M	25

Questions about Verdad Advisers, LP's portfolio

What stocks does Verdad Advisers, LP own?

Verdad Advisers, LP's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 210 positions worth $104.4M. The largest are Apple Inc (AAPL) at 2.1%, Belite Bio Inc (BLTE) at 2.0%, Acadia Pharmaceuticals Inc (ACAD) at 2.0%, Comcast Corp New (CMCSA) at 2.0% and Chatham Lodging Tr (CLDT) at 1.8%.

What did Verdad Advisers, LP buy last quarter?

In Q2 2026, Verdad Advisers, LP added Versant Media Group Inc (VSNTV) (+129.0% shares), Comcast Corp New (CMCSA) (+103.5% shares) and Tenax Therapeutics Inc (TENX) (+29.2% shares), compared with its Q1 2026 filing.

What did Verdad Advisers, LP sell last quarter?

In Q2 2026, Verdad Advisers, LP cut from its top 50 State Str Corp (STT), cut from its top 50 Autohome Inc (ATHM), cut from its top 50 Cal Maine Foods Inc (CALM), cut from its top 50 Zoom Communications Inc (ZM), cut from its top 50 California Res Corp, Revolution Medicines Inc (RVMD) (-81.2% shares), Applied Matls Inc (AMAT) (-62.4% shares) and Design Therapeutics, Inc. (DSGN) (-48.5% shares), compared with its Q1 2026 filing.

How has Verdad Advisers, LP's portfolio performed?

A portfolio copying Verdad Advisers, LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +22.3% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: +31.4% against +11.7%. Over 5 years: +9.9% a year against +10.6%.

When is Verdad Advisers, LP's next 13F filing due?

13F filings are due 45 days after each quarter ends. Verdad Advisers, LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.